THE 14TH ANNUAL SHORTY AWARDS

The Shorty Awards honor the best of social media and digital. View this season's finalists!

Outnumber PAH

Entered in Long Form Video, Storytelling

Objective

Situation Analysis:

Pulmonary arterial hypertension (PAH) is a matter of life and death. A rare, incurable and progressive disease, PAH causes blood vessels in the lungs to thicken and narrow, which makes the heart work harder to pump blood through the lungs. There’s no cure. The five-year mortality rate is ~43%; it takes around two years to be diagnosed after symptoms start. PAH patients are typically between 30-60 years of age – the prime of their lives – when diagnosed.

Life with PAH can be difficult: Patients often experience difficulty breathing, fatigue and chest pain. Daily life accommodations are often required; in some cases, a task that once took an hour may take days. There’s also a profound emotional and psychological impact. Patients often feel overwhelmed, isolated and worried. With only 40,000 people in the U.S. living with PAH, we saw a need to develop an inspirational, action-oriented campaign to encourage community, help improve patients’ outlook and provide tools to better manage everyday challenges.

Enter “Outnumber PAH,” developed by Merck and Real Chemistry, to urge patients to build a strong multidisciplinary team that can help “outnumber” the disease and advocate for themselves. Outnumber PAH was developed in collaboration with leading PAH advocacy organizations.

Campaign Objectives:

Strategy

Target Audience:

Diagnosed patients with PAH in the U.S., age 30 to 60 and their support systems (e.g., friends, family, caregivers and healthcare providers)

Research:

Insight:
A PAH diagnosis can change everything, but having a team of people to support you can make a difference.

Strategy:
Highlight real patients’ stories to illustrate how connecting with others and forming a strong support team can be a source of optimism and inspiration.

Execution & Tactics:
The campaign weaves together patient stories of challenges and triumphs to paint a detailed picture of what it’s like to live with the disease and encourage people to seek support.

Our PAH advocacy partners – the Pulmonary Hypertension Association, phaware, and the National Scleroderma Foundation – helped identify featured patients and caregivers and distributed materials.

The heart of the campaign is a hero video featuring two patients – both young mothers – who met online through the PAH community and had been supporting each other from afar. They had never met in person until we brought them together in a surprise meeting.

Additional tactical elements:

Results

The campaign drove thousands of patients to learn more about the role of a support team in navigating PAH and to get the right medical care team support. This is significant reach considering PAH is a rare disease, affecting only an estimated 40,000 patients in the U.S.

Results aligned to campaign objectives:

Inspire people with PAH to seek out comprehensive support

Raise awareness of the importance of support and self-advocacy in managing PAH

Importantly, response from the PAH community was overwhelmingly positive:

Media Coverage (for reference):

Media

Video for Outnumber PAH

Entrant Company / Organization Name

Real Chemistry, Merck

Links

Entry Credits